Pneumonia Testing Market Set to Soar to $3.0 Billion Globally by 2030, Reveals Allied Market Research
PORTLAND, OREGON, UNITED STATES, November 30, 2023 /EINPresswire.com/ -- In the dynamic landscape of healthcare diagnostics, Allied Market Research commemorates its one-year journey with a comprehensive report titled, "Pneumonia Testing Market: Global Opportunity Analysis and Industry Forecast, 2020-2030." This detailed analysis explores the diverse facets of the market, encompassing types, methods, technologies, and end-users.
Key Findings and Growth Projection:
The report reveals that the global pneumonia testing industry, valued at $1.6 billion in 2020, is poised to reach $3.0 billion by 2030, indicating a robust Compound Annual Growth Rate (CAGR) of 6.5% from 2021 to 2030. Drivers such as the increased adoption of point-of-care testing and advancements in nucleic acid detection technologies contribute significantly to this growth trajectory.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅:
𝐅𝐨𝐫 𝐚 𝐝𝐞𝐞𝐩𝐞𝐫 𝐮𝐧𝐝𝐞𝐫𝐬𝐭𝐚𝐧𝐝𝐢𝐧𝐠 𝐨𝐟 𝐦𝐚𝐫𝐤𝐞𝐭 𝐭𝐫𝐞𝐧𝐝𝐬 𝐚𝐧𝐝 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐩𝐫𝐨𝐟𝐞𝐬𝐬𝐢𝐨𝐧𝐚𝐥𝐬 𝐜𝐚𝐧 𝐚𝐜𝐜𝐞𝐬𝐬 𝐭𝐡𝐞 𝐬𝐚𝐦𝐩𝐥𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐡𝐞𝐫𝐞: https://www.alliedmarketresearch.com/request-sample/3776
Drivers, Restraints, and Opportunities:
The report delves into the factors influencing market dynamics, highlighting the impact of the rise in healthcare expenditure, advanced healthcare infrastructure, and the availability of reimbursements as key opportunities. While the adoption of point-of-care testing is a driver, the report also recognizes the challenge posed by the continued use of traditional culture methods in detecting pneumonia causative organisms.
Covid-19 Impact:
In the context of the global pandemic, the report underscores the positive impact on the pneumonia testing market. Individuals afflicted with Covid-19 exhibit a heightened susceptibility to pneumonia, driving market growth. Additionally, increased research and development activities related to the treatment of Covid-19-associated pneumonia contribute to the market's upward trajectory.
Segmental Dominance and Projections:
Types: The analyzers segment, constituting over two-thirds of the market share in 2020, is anticipated to maintain its dominance through 2030. Meanwhile, the consumables segment is projected to witness the fastest CAGR of 7.0% due to the frequent usage of pneumonia tests.
Methods: Point of care testing, holding nearly three-fifths of the market revenue in 2020, is expected to continue its dominance and manifest the fastest CAGR of 6.9% from 2021 to 2030.
Regional Insights:
North America led the market in 2020, generating approximately two-fifths of the global pneumonia testing market. The prevalence of chronic diseases and the emergence of advanced healthcare infrastructure drive growth in this region. Meanwhile, the Asia-Pacific region is anticipated to experience the fastest CAGR of 7.5% by 2030, attributed to the rise in the geriatric population suffering from infectious diseases.
Key Industry Players:
The competitive landscape is marked by the presence of key players such as Abbott Laboratories, Thermo Fisher Scientific Inc., F-Hoffmann la Roche Ltd., Hologic Inc., BioMerieux, Becton, Quidel, Dickenson and Company, Meridian Biosciences, Quest Diagnostics, and Bio-Rad Laboratories Inc.
𝐓𝐨 𝐞𝐱𝐩𝐥𝐨𝐫𝐞 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐚𝐧𝐝 𝐦𝐚𝐤𝐞 𝐢𝐧𝐟𝐨𝐫𝐦𝐞𝐝 𝐝𝐞𝐜𝐢𝐬𝐢𝐨𝐧𝐬, 𝐚𝐜𝐜𝐞𝐬𝐬 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐫𝐞𝐩𝐨𝐫𝐭 𝐚𝐧𝐝 𝐦𝐚𝐤𝐞 𝐢𝐧𝐪𝐮𝐢𝐫𝐢𝐞𝐬 𝐚𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/3776
Trending Reports in Healthcare Industry:
Age Related Macular Degeneration (AMD) Market - https://www.alliedmarketresearch.com/age-related-macular-degeneration-AMD-market
Intravascular Temperature Management Market - https://www.alliedmarketresearch.com/intravascular-temperature-management-market
India surgical mask market - https://www.alliedmarketresearch.com/surgical-mask-market
pharmacogenomics market - https://www.alliedmarketresearch.com/pharmacogenomics-market
Artificial Intelligence For Drug Development and Discovery Market - https://www.alliedmarketresearch.com/artificial-intelligence-for-drug-development-and-discovery-market
David Correa
Allied Analytics LLP
+ +1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
